Choksi Laboratories Limited has appointed Ankit Consultancy Private Limited as its new Registrar and Share Transfer Agent (RTA), replacing MUFG Intime India Private Limited effective August 03, 2026. The transition ensures uninterrupted electronic connectivity with depositories for share transfers. To ensure stakeholder awareness, the company published a notice regarding this change in Free Press Journal (English) and Choutha Sansar (Hindi) on August 04, 2026.

The appointment follows a comprehensive evaluation of service offerings, technological capabilities, and local convenience. Choksi Laboratories executed the change in compliance with Regulation 30 read with Schedule III Part A(A) and Regulation 47(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also referenced SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, in its intimation to BSE Limited.

Transition Details

National Securities Depository Limited (NSDL) notified the company on July 31, 2026, confirming that MUFG Intime would cease acting as the RTA for electronic connectivity from the beginning of August 03, 2026, while Ankit Consultancy commenced operations simultaneously. Central Depository Services (India) Limited (CDSL) confirmed in a letter dated August 03, 2026, that it had effected the system change and cancelled the tripartite agreement with the previous RTA.

Stakeholder Instructions

Shareholders, Beneficial Owners, and Depository Participants are requested to direct all investor service requests, complaints, and documents to Ankit Consultancy Private Limited at Unit: Choksi Laboratories Limited, 60, Electronic Complex, Pardeshipura, Indore (M.P.) 452010. Contact numbers are 09752344442 and 0731-4065799, with email addresses info@ankitonline.com and investor@ankitonline.com . Documents may also be sent to the company’s registered office at Survey No. 9/1, Near Tulsiana Industrial Park, Gram Kurnadi, Indore-453555 (M.P.).

Procedural Compliance

Under Regulation 7 of the Listing Regulations, Choksi Laboratories is required to execute a Tripartite Agreement involving the company, MUFG Intime India Private Limited, and Ankit Consultancy Private Limited. The company indicated that this agreement will be executed in due course and intimated to stock exchanges within statutory timelines. Prakhar Dubey, Company Secretary and Compliance Officer of Choksi Laboratories, signed the disclosure. The information is available on the company’s website, www.choksilab.in .

Choksi Laboratories Limited reported a 29% increase in net profit to ₹196.43 lakh for the financial year ended March 31, 2026, compared to ₹152.33 lakh in the previous year. The company's revenue from operations for FY26 stood at ₹4600.59 lakh, up from ₹4178.23 lakh in FY25. The Board of Directors approved the audited financial results during a meeting held on May 25, 2026, and the results were published in newspapers on May 26, 2026, in compliance with Regulation 47 of the SEBI (LODR) Regulations, 2015.

Financial Performance

For the quarter ended March 31, 2026, the company recorded a net profit of ₹102.68 lakh, compared to ₹92.13 lakh in the corresponding quarter of the previous year. Total revenue for the year ended March 31, 2026, reached ₹4621.93 lakh. Profit before tax for the year was ₹319.46 lakh, higher than the ₹215.33 lakh recorded in the preceding financial year. The basic and diluted earnings per share (EPS) for the year were ₹2.82, compared to ₹2.19 in the previous year.

Operational Details

Choksi Laboratories identified "Analysis and Testing" as its single operating segment. The statutory auditors, M/s Prateek Jain & Co., Chartered Accountants, issued an unmodified opinion on the financial results. During the quarter, the company sold an office flat, resulting in a gain of ₹75.30 lakh, which was disclosed as an exceptional item.

Assets and Cash Flow

As of March 31, 2026, the company's total assets were valued at ₹7192.08 lakh, an increase from ₹6533.21 lakh in the previous year. Total equity stood at ₹2557.54 lakh, while total liabilities were recorded at ₹4634.54 lakh. Cash and cash equivalents at the end of the financial year stood at ₹20.67 lakh. Net cash generated from operating activities was ₹786.48 lakh, while investing activities resulted in a net cash outflow of ₹707.46 lakh.